BCKDK and epilepsy: ASD, epilepsy, and ID comorbidity has also been characterized by amino acid metabolism dysfunctions such as inactivating mutations in branched-chain ketoacid dehydrogenase kinase (BCKDK) or amino acid transporter (SlC7A5) [43], altering brain amino acid profiles and causing neurobehavioral deficits in both humans and mice [43].